Pharma benefited from basing business overseas. An international tax effort could spur a rethink.
BioPharma Drive: Drug Pricing
NOVEMBER 28, 2023
Now, a push for an international floor could disrupt their R&D accounting. tax law changes enacted six years ago slashed large pharma companies' rates and saved them billions.
Let's personalize your content